Structure-Activity Relationships and Anti-inflammatory Activities of N-Carbamothioylformamide Analogues as MIF Tautomerase Inhibitors
暂无分享,去创建一个
Yu Zhang | Feng Liu | Zhiqiang Zhang | Lei Xu | Tingjun Hou | Youyong Li | Zhiyu Zhang | Dan Li | Kunqian Yu | Xuechu Zhen | Longtai Zheng | Kunqian Yu | Feng Liu | Youyong Li | Xuechu Zhen | L. Zheng | Dan Li | Tingjun Hou | Lei Xu | Yu Zhang | Zhiyu Zhang | Zhiqiang Zhang | Feng Liu
[1] Mark A. Murcko,et al. Virtual screening : an overview , 1998 .
[2] Youyong Li,et al. Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays. , 2014, Journal of medicinal chemistry.
[3] J. Bernhagen,et al. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). , 1994, Biochemistry.
[4] Tingjun Hou,et al. Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches. , 2012, Molecular pharmaceutics.
[5] T. Calandra,et al. Macrophage migration inhibitory factor: a regulator of innate immunity , 2003, Nature Reviews Immunology.
[6] Markus Zweckstetter,et al. A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor. , 2009, Biochemistry.
[7] Peter D. Senter,et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] Peter A. Ward,et al. Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.
[9] Xuechu Zhen,et al. Design, synthesis and evaluation of a series of non-steroidal anti-inflammatory drug conjugates as novel neuroinflammatory inhibitors. , 2015, International immunopharmacology.
[10] Tingjun Hou,et al. ADME Evaluation in Drug Discovery, 7. Prediction of Oral Absorption by Correlation and Classification , 2007, J. Chem. Inf. Model..
[11] William L. Jorgensen,et al. Crystallographic and Receptor Binding Characterization of Plasmodium falciparum Macrophage Migration Inhibitory Factor Complexed to Two Potent Inhibitors , 2014, Journal of medicinal chemistry.
[12] M. Rosengart,et al. Heme oxygenase‐1–mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice , 2011, Hepatology.
[13] A. Ferguson,et al. Gram-positive toxic shock syndromes. , 2009, The Lancet. Infectious diseases.
[14] J M Briggs,et al. Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism , 2000, Journal of molecular recognition : JMR.
[15] K. Suk,et al. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production , 2008, Journal of neurochemistry.
[16] Guenter Grethe,et al. Similarity searching in REACCS. A new tool for the synthetic chemist , 1990, J. Chem. Inf. Comput. Sci..
[17] M. Alcaraz,et al. Anti-inflammatory actions of the heme oxygenase-1 pathway. , 2003, Current pharmaceutical design.
[18] Zoe Cournia,et al. Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. , 2009, Journal of medicinal chemistry.
[19] Julian Tirado-Rives,et al. Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factor. , 2012, Journal of medicinal chemistry.
[20] Michael Bacher,et al. ISO-1 Binding to the Tautomerase Active Site of MIF Inhibits Its Pro-inflammatory Activity and Increases Survival in Severe Sepsis* , 2005, Journal of Biological Chemistry.
[21] I. Tanaka,et al. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution. , 1999, Biochemistry.
[22] P Franchimont,et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. , 1992, Annals of surgery.
[23] Fali Zhang,et al. 1-O-tigloyl-1-O-deacetyl-nimbolinin B inhibits LPS-stimulated inflammatory responses by suppressing NF-κB and JNK activation in microglia cells. , 2014, Journal of pharmacological sciences.
[24] C. Nathan,et al. Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] J. Bernhagen,et al. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. , 2007, Molecular endocrinology.
[26] R. Kleemann,et al. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. , 1998, Journal of molecular biology.
[27] Elias Lolis,et al. The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents* , 2002, The Journal of Biological Chemistry.
[28] Elias Lolis,et al. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor , 1998, The EMBO journal.
[29] R. Bucala,et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.
[30] Markus Zweckstetter,et al. Identification and Characterization of Novel Classes of Macrophage Migration Inhibitory Factor (MIF) Inhibitors with Distinct Mechanisms of Action* , 2010, The Journal of Biological Chemistry.
[31] Jawed Alam,et al. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. , 2006, Physiological reviews.
[32] Peter A. Ward,et al. Novel strategies for the treatment of sepsis , 2003, Nature Medicine.
[33] Y. Al-Abed,et al. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity. , 2006, Bioorganic & medicinal chemistry letters.
[34] Peter Björk,et al. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase , 1997, FEBS letters.
[35] Huiyong Sun,et al. Current developments of macrophage migration inhibitory factor (MIF) inhibitors. , 2013, Drug discovery today.
[36] T. Lóránd,et al. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments. , 2009, Current medicinal chemistry.
[37] J. Bernhagen,et al. Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[38] Valentin A. Pavlov,et al. Phenolic hydrazones are potent inhibitors of macrophage migration inhibitory factor proinflammatory activity and survival improving agents in sepsis. , 2007, Journal of medicinal chemistry.
[39] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[40] K. Tracey,et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.
[41] H. Okamura,et al. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. , 1992, Journal of immunology.
[42] R. Friesner,et al. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .
[43] John O Trent,et al. A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. , 2008, Cancer research.
[44] Lisa C Parker,et al. Differential and cell‐type specific regulation of responses to Toll‐like receptor agonists by ISO‐1 , 2008, Immunology.
[45] Lei Chen,et al. Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicines , 2013, Journal of Cheminformatics.
[46] Vincent Richard,et al. Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[47] E Lolis,et al. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. , 1999, Biochemistry.
[48] Michael Tsokos,et al. Immunohistochemical expression of tumor necrosis factor-α in sepsis-induced lung injury , 2006, Forensic science, medicine, and pathology.
[49] J. Bernhagen,et al. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis , 2006, Nature Reviews Drug Discovery.